Literature DB >> 17129179

Osteosarcoma and teriparatide?

Kristine D Harper, John H Krege, Robert Marcus, Bruce H Mitlak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17129179     DOI： 10.1359/jbmr.061111

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  32 in total

1.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

Review 2.  Parathyroid hormone analogues in the treatment of osteoporosis.

Authors:  Marius E Kraenzlin; Christian Meier
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

4.  Osteoprotection Through the Deletion of the Transcription Factor Rorβ in Mice.

Authors:  Joshua N Farr; Megan M Weivoda; Kristy M Nicks; Daniel G Fraser; Brittany A Negley; Jennifer L Onken; Brianne S Thicke; Ming Ruan; Hong Liu; Douglas Forrest; John R Hawse; Sundeep Khosla; David G Monroe
Journal:  J Bone Miner Res       Date:  2017-12-27       Impact factor: 6.741

5.  Effects of bone remodeling agents following teriparatide treatment.

Authors:  D Burkard; T Beckett; E Kourtjian; C Messingschlager; R Sipahi; M Padley; J Stubbart
Journal:  Osteoporos Int       Date:  2018-03-14       Impact factor: 4.507

Review 6.  Clinical update on teriparatide.

Authors:  Elizabeth File; Chad Deal
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 7.  Osteoporosis and treatments in Japan: management for preventing subsequent fractures.

Authors:  Shuko Nojiri; Russel T Burge; Jennifer A Flynn; Shonda A Foster; Hideaki Sowa
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

8.  Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis.

Authors:  Luca Pietrogrande
Journal:  Int J Womens Health       Date:  2010-08-09

Review 9.  MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.

Authors:  Ernesto Canalis
Journal:  Eur J Endocrinol       Date:  2017-11-07       Impact factor: 6.664

Review 10.  Parathyroid hormone applications in the craniofacial skeleton.

Authors:  H L Chan; L K McCauley
Journal:  J Dent Res       Date:  2012-10-15       Impact factor: 6.116
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.